Supportive Care in Cancer

, Volume 18, Issue 8, pp 1033–1038 | Cite as

A systematic review of trismus induced by cancer therapies in head and neck cancer patients

  • Rene-Jean BensadounEmail author
  • Dorothea Riesenbeck
  • Peter B. Lockhart
  • Linda S. Elting
  • Fred K. L. Spijkervet
  • Mike T. Brennan
  • Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)
Review Article



This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.


A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.


We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.


Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.


Cancer therapy Trismus Management strategies 


Conflict of interest statement

None to declare.


  1. 1.
    Brennan MT, Spijkervet FKL, Elting LS (2010) Methodology review. Support Care Cancer (in press)Google Scholar
  2. 2.
    Chao CK, Ozyigit G, Blanco AI, Thorstad WL, Deasy JO, Haughey BH, Spector GJ, Sessions DG (2004) Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59:43–50PubMedGoogle Scholar
  3. 3.
    Chen AM, Bucci MK, Singer MI, Garcia J, Kaplan MJ, Chan AS, Phillips TL (2007) Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience. Int J Radiat Oncol Biol Phys 67:122–129PubMedGoogle Scholar
  4. 4.
    Chua DT, Lo C, Yuen J, Foo YC (2001) A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24:366–369CrossRefPubMedGoogle Scholar
  5. 5.
    Daoud J, Toumi N, Bouaziz M, Ghorbel A, Jlidi R, Drira MM, Frikha M (2003) Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 39:2349–2354CrossRefPubMedGoogle Scholar
  6. 6.
    Dijkstra PU, Huisman PM, Roodenburg JL (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–342CrossRefPubMedGoogle Scholar
  7. 7.
    Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40:879–889CrossRefPubMedGoogle Scholar
  8. 8.
    Eisen MD, Weinstein GS, Chalian A, Machtay M, Kent K, Coia LR, Weber RS (2000) Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol 21:312–317CrossRefPubMedGoogle Scholar
  9. 9.
    Grandi G, Silva ML, Streit C, Wagner JC (2007) A mobilization regimen to prevent mandibular hypomobility in irradiated patients: an analysis and comparison of two techniques. Med Oral Patol Oral Cir Bucal 12:E105–E109PubMedGoogle Scholar
  10. 10.
    Hartl DM, Cohen M, Juliéron M, Marandas P, Janot F, Bourhis J (2008) Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg 138:459–463CrossRefPubMedGoogle Scholar
  11. 11.
    Hsiung CY, Huang EY, Ting HM, Huang HY (2008) Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 81:809–814CrossRefPubMedGoogle Scholar
  12. 12.
    Kent ML, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC, Lockhart PB (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16:305–309CrossRefGoogle Scholar
  13. 13.
    Keus RB, Pontvert D, Brunin F, Jaulerry BJP (1988) Result of irradiation in squamous cell carcinoma of the soft palate and uvula. Radiother Oncol 11:311–317CrossRefPubMedGoogle Scholar
  14. 14.
    Laskin DM, Greene CS, Hylander WL (2006) Temporomandibular disorders: an evidence-based approach to diagnosis and treatment. Quintessence, ChicagoGoogle Scholar
  15. 15.
    Le Scodan R, Pommier R, Ardiet JM, Montbarbon X, Malet C, Favrel V, Zrounba P, Poupart M, Céruse P, Ferlay C, Clippe S (2005) Exclusive brachytherapy for T1 and T2 squamous cell carcinomas of the velotonsillar area: results in 44 patients. Int J Radiat Oncol Biol Phys 63:441–448PubMedGoogle Scholar
  16. 16.
    Levendag P, Nijdam W, Noever I, Schmitz P, Van de Pol M, Sipkema D, Braat C, De Boer M, Jansen P (2004) Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing? Int J Radiat Oncol Biol Phys 59:713–724PubMedGoogle Scholar
  17. 17.
    Melchers LJ, Van Weert E, Beurskens CH, Reintsema H, Slagter AP, Roodenburg JL, Dijkstra PU (2009) Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite. Int J Oral Maxillofac Surg 38:947–954CrossRefPubMedGoogle Scholar
  18. 18.
    Palazzi M, Guzzo M, Bossi P, Tomatis S, Cerrotta A, Cantú G, Locati LD, Licitra L (2004) Regionally advanced nasopharyngeal carcinoma: long-term outcome after sequential chemotherapy and radiotherapy. Tumori 90:60–65PubMedGoogle Scholar
  19. 19.
    Palazzi M, Guzzo M, Tomatis S, Cerrotta A, Potepan P, Quattrone P, Cantù G (2004) Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 60:1451–1458PubMedGoogle Scholar
  20. 20.
    Peterson DE et al. Systematic Review Osteoradionecrosis (2010) Support Care Cancer (in press)Google Scholar
  21. 21.
    Ozsaran Z, Yalman D, Baltalarli B, Anacak Y, Esassolak M, Haydaroğlu A (2003) Radiotherapy in maxillary sinus carcinomas: evaluation of 79 cases. Rhinology 41:44–48PubMedGoogle Scholar
  22. 22.
    Shulman DH, Shipman B, Willis FB (2008) Treating trismus with dynamic splinting: a cohort, case series. Adv Ther 25:9–15CrossRefPubMedGoogle Scholar
  23. 23.
    Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK (2000) Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University Of California—San Francisco experience. Int J Radiat Oncol Biol Phys 48:711–722PubMedGoogle Scholar
  24. 24.
    Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de Kruijf W, van Rooij P, Schmitz PI, Heijmen BJ (2008) Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 30:622–630CrossRefPubMedGoogle Scholar
  25. 25.
    Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115:1458–1460CrossRefPubMedGoogle Scholar
  26. 26.
    Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ (2007) Quality of life of nasopharyngeal carcinoma survivors in Mainland China. Qual Life Res 16:65–74CrossRefPubMedGoogle Scholar
  27. 27.
    Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY (2005) Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62:672–679PubMedGoogle Scholar
  28. 28.
    NCI (1990) National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17–19, 1989. NCI Monogr 9:1–184Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Rene-Jean Bensadoun
    • 1
    Email author
  • Dorothea Riesenbeck
    • 2
  • Peter B. Lockhart
    • 3
  • Linda S. Elting
    • 4
  • Fred K. L. Spijkervet
    • 5
  • Mike T. Brennan
    • 3
  • Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)
  1. 1.Radiotherapy Department, Pôle Régional de CancérologieCHU de PoitiersPoitiers Cedex 9France
  2. 2.RecklinghausenGermany
  3. 3.Department of Oral MedicineCarolinas Medical CenterCharlotteUSA
  4. 4.Department of BiostatisticsThe University of Texas M. D. Anderson Cancer CenterHoustonUSA
  5. 5.Department of Oral & Maxillofacial Surgery, University Medical Center GroningenUniversity of GroningenGroningenThe Netherlands

Personalised recommendations